These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26950764)

  • 1. CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense.
    Carevic M; Öz H; Fuchs K; Laval J; Schroth C; Frey N; Hector A; Bilich T; Haug M; Schmidt A; Autenrieth SE; Bucher K; Beer-Hammer S; Gaggar A; Kneilling M; Benarafa C; Gao JL; Murphy PM; Schwarz S; Moepps B; Hartl D
    J Innate Immun; 2016; 8(4):362-73. PubMed ID: 26950764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic cleavage of the long pentraxin PTX3 in the airways of cystic fibrosis patients.
    Hamon Y; Jaillon S; Person C; Giniès JL; Garo E; Bottazzi B; Ghamrawi S; Urban T; Subra JF; Bouchara JP; Mantovani A; Jeannin P; Delneste Y
    Innate Immun; 2013 Dec; 19(6):611-22. PubMed ID: 23475792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease.
    Koller B; Kappler M; Latzin P; Gaggar A; Schreiner M; Takyar S; Kormann M; Kabesch M; Roos D; Griese M; Hartl D
    J Immunol; 2008 Aug; 181(4):2753-63. PubMed ID: 18684966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice.
    Carrigan SO; Junkins R; Yang YJ; Macneil A; Richardson C; Johnston B; Lin TJ
    J Immunol; 2010 Sep; 185(6):3602-9. PubMed ID: 20720199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.
    Rieber N; Brand A; Hector A; Graepler-Mainka U; Ost M; Schäfer I; Wecker I; Neri D; Wirth A; Mays L; Zundel S; Fuchs J; Handgretinger R; Stern M; Hogardt M; Döring G; Riethmüller J; Kormann M; Hartl D
    J Immunol; 2013 Feb; 190(3):1276-84. PubMed ID: 23277486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils from F508del cystic fibrosis patients produce IL-17A and express IL-23 - dependent IL-17RC.
    Taylor PR; Bonfield TL; Chmiel JF; Pearlman E
    Clin Immunol; 2016 Sep; 170():53-60. PubMed ID: 27155366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease.
    Cobb LM; Mychaleckyj JC; Wozniak DJ; López-Boado YS
    J Immunol; 2004 Nov; 173(9):5659-70. PubMed ID: 15494517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils Kill Reactive Oxygen Species-Resistant Pseudomonas aeruginosa by Sphingosine.
    Becker KA; Li X; Seitz A; Steinmann J; Koch A; Schuchman E; Kamler M; Edwards MJ; Caldwell CC; Gulbins E
    Cell Physiol Biochem; 2017; 43(4):1603-1616. PubMed ID: 29040968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin-1 Restricts Interleukin-36γ-Mediated Neutrophilic Inflammation during Pseudomonas aeruginosa Pulmonary Infection.
    Peñaloza HF; Olonisakin TF; Bain WG; Qu Y; van der Geest R; Zupetic J; Hulver M; Xiong Z; Newstead MW; Zou C; Alder JK; Ybe JA; Standiford TJ; Lee JS
    mBio; 2021 Apr; 12(2):. PubMed ID: 33824208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
    Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis.
    McIsaac SM; Stadnyk AW; Lin TJ
    J Leukoc Biol; 2012 Nov; 92(5):977-85. PubMed ID: 22892106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal/Permeability-Increasing Protein Preeminently Mediates Clearance of
    Theprungsirikul J; Skopelja-Gardner S; Burns AS; Wierzbicki RM; Rigby WFC
    Front Immunol; 2021; 12():659523. PubMed ID: 33981306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
    Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
    Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.
    Malhotra S; Hayes D; Wozniak DJ
    Clin Microbiol Rev; 2019 Jun; 32(3):. PubMed ID: 31142499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel host defense system of airways is defective in cystic fibrosis.
    Moskwa P; Lorentzen D; Excoffon KJ; Zabner J; McCray PB; Nauseef WM; Dupuy C; Bánfi B
    Am J Respir Crit Care Med; 2007 Jan; 175(2):174-83. PubMed ID: 17082494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.
    Reiniger N; Lee MM; Coleman FT; Ray C; Golan DE; Pier GB
    Infect Immun; 2007 Apr; 75(4):1598-608. PubMed ID: 17283089
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Öz HH; Zhou B; Voss P; Carevic M; Schroth C; Frey N; Rieber N; Hector A; Hartl D
    Front Cell Infect Microbiol; 2016; 6():167. PubMed ID: 27965936
    [No Abstract]   [Full Text] [Related]  

  • 19. UPR modulation of host immunity by Pseudomonas aeruginosa in cystic fibrosis.
    Bedi B; Lin KC; Maurice NM; Yuan Z; Bijli K; Koval M; Hart CM; Goldberg JB; Stecenko A; Sadikot RT
    Clin Sci (Lond); 2020 Jul; 134(14):1911-1934. PubMed ID: 32537652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulators of sphingolipid metabolism reduce lung inflammation.
    Dechecchi MC; Nicolis E; Mazzi P; Cioffi F; Bezzerri V; Lampronti I; Huang S; Wiszniewski L; Gambari R; Scupoli MT; Berton G; Cabrini G
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):825-33. PubMed ID: 21659660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.